These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 762635)
1. Local steroid therapy of refractory ascites associated with dialysis. Pascual JF; Melendez MT; Rivera-Viera JF J Pediatr; 1979 Feb; 94(2):319-20. PubMed ID: 762635 [No Abstract] [Full Text] [Related]
2. Local steroid treatment of intractable ascites in dialysis patients. Buselmeier TJ; Simmons RL; Duncan DA; Toledo LH; Mauer SM; Matas AJ; Hong C; Najarian JS; Kjellstrand CM Proc Clin Dial Transplant Forum; 1975 Nov; 5():9-11. PubMed ID: 1232636 [No Abstract] [Full Text] [Related]
3. Intraperitoneal infusion of a nonabsorbable steroid in hemodialysis-associated ascites. Bansal VK; Popli S; Ing TS; Hano JE; Geis WP; Kamadana MR J Dial; 1978; 2(4):379-85. PubMed ID: 721992 [TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal infusion of non-absorbable steroids in the treatment of ascites and sterile peritonitis. Diaz-Buxo JA; Chandler JT; Farmer CD; Walker PJ J Dial; 1980; 4(1):43-50. PubMed ID: 7410677 [TBL] [Abstract][Full Text] [Related]
5. Idiopathic ascites of haemodialysis: response to treatment. Jones BF; Trevillian PR; Nandra RS Br Med J; 1976 Apr; 1(6014):877. PubMed ID: 1260387 [No Abstract] [Full Text] [Related]
6. Treatment of idiopathic ascites of haemodialysis. Buselmeier TJ Br Med J; 1976 Dec; 2(6051):1562. PubMed ID: 1009404 [No Abstract] [Full Text] [Related]
7. ACE inhibitors in the management of haemodialysis ascites. Roy-Chaudhury P; Edward N Nephrol Dial Transplant; 1994; 9(11):1695-6. PubMed ID: 7870368 [No Abstract] [Full Text] [Related]
8. Ascites in patients undergoing intermittent haemodialysis at Kenyatta National Hospital. McLigeyo SO; Otieno LS; Kinuthia DM; Mwongera FK; Ongeri SK East Afr Med J; 1991 Oct; 68(10):789-94. PubMed ID: 1813302 [TBL] [Abstract][Full Text] [Related]
9. Pilot study of intraperitoneal administration of triamcinolone acetonide for cancerous ascites in patients with end-stage gynecological cancer. Shoji T; Takatori E; Miura Y; Takada A; Omi H; Kagabu M; Honda T; Miura F; Takeuchi S; Sugiyama T Int J Gynecol Cancer; 2014 Jul; 24(6):1093-7. PubMed ID: 24978712 [TBL] [Abstract][Full Text] [Related]
11. The use of intraperitoneal triamcinolone acetonide for the management of recurrent malignant ascites in a patient with non-Hodgkin's lymphoma. Jenkin RP; Bamford R; Patel V; Kelly L; Stern S J Pain Symptom Manage; 2008 Nov; 36(5):e4-5. PubMed ID: 18789636 [No Abstract] [Full Text] [Related]
12. [Local treatment of juvenile oligoarthritis with triamcinolone hexacetonide]. Job-Deslandre C; Menkes CJ; Canlorbe P Presse Med; 1986 Jul 5-12; 15(27):1282-3. PubMed ID: 2945186 [No Abstract] [Full Text] [Related]
13. [Testing of a triamcinolone acetonide derivative in various dermatosis]. Gasca JM; Serrano HG; Ponzán MA; Bajo JA; Garcés FM Actas Dermosifiliogr; 1975; 66(7-8):387-94. PubMed ID: 1180142 [No Abstract] [Full Text] [Related]
15. Use of triamcinolone hexacetonide for the treatment of osteoarthritis of the hip: comment on the letter by Margules. Kahn C Arthritis Rheum; 2002 Sep; 46(9):2546-7; author reply 2547. PubMed ID: 12355514 [No Abstract] [Full Text] [Related]
16. What should be done to treat dialysis-associated ascites? Jhaveri KD; Miller IJ Semin Dial; 2011; 24(4):368-9. PubMed ID: 21801212 [No Abstract] [Full Text] [Related]